NeuroPace names Patrick Williams as CFO; Rebecca Kuhn departs after 25 years

NeuroPace Inc

Rebecca Kuhn stepped down as CFO on June 20, 2025; will serve as Senior Strategic Advisor through June 19, 2026.
Kuhn receives 12 months base salary severance, 18 months COBRA, $88,885 pro-rated bonus, and continued equity vesting.
Patrick F. Williams appointed CFO effective June 20; previously CFO at STAAR Surgical (2024 net sales >$300M).
Williams' base salary $500,000, target bonus 60%, plus equity awards: 51,850 RSUs and 87,950 options with 4-year vest.
CEO Joel Becker noted Williams' experience scaling medical device companies; thanked Kuhn for 25-year tenure.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Patrick F. Williams

Chief Financial Officer

NPCE · NeuroPace Inc

Effective: 2025-06-20
Filed: Jun 24, 2025 23:59 UTC

the Company has appointed Patrick F. Williams as Chief Financial Officer, effective as of the Transition Date.

Role change

Rebecca Kuhn

Chief Financial Officer

NPCE · NeuroPace Inc

Effective: 2025-06-20
Successor: Patrick F. Williams
Filed: Jun 24, 2025 23:59 UTC

On June 20, 2025, Rebecca Kuhn departed from her position as Chief Financial Officer and Vice President, Finance and Administration of NeuroPace, Inc.

Source: SEC EDGAR

accession 0001193125-25-145738

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.